SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 1-A - Offering Statement [Regulation A]:
SEC Accession No. 0001104659-20-001888
Filing Date
2020-01-07
Accepted
2020-01-07 13:18:13
Documents
4

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-A  
1 primary_doc.xml 1-A 9262
2 PART II AND III tm201367d1_partiiandiii.htm PART II AND III 1296193
3 GRAPHIC tm201367d1_form1a-img01.jpg GRAPHIC 24823
4 EXHIBIT 11.1 tm201367d1_ex11-1.htm EX1A-11 CONSENT 2562
  Complete submission text file 0001104659-20-001888.txt   1343529
Mailing Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170 (212) 479-2513
Scopus BioPharma Inc. (Filer) CIK: 0001772028 (see all company filings)

IRS No.: 821248020 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 1-A | Act: 33 | File No.: 024-11137 | Film No.: 20512816
SIC: 2834 Pharmaceutical Preparations